Skip to navigation Skip to content

News

Share

NIH Researcher Receives Prestigious Barancik Prize for Innovation in MS Research

November 2, 2016

Daniel Reich, M.D., Ph.D., recognized for his innovative ways of looking at the brain to advance knowledge of MS


Dr. Daniel Reich, a physician-scientist with the National Institutes of Health, has been selected as the winner of the 2016 Barancik Prize for Innovation in MS Research. Dr. Reich directs the Translational Neuroradiology Section within the Division of Neuroimmunology and Neurovirology of the National Institute of Neurological Disorders and Stroke. Reich is a neurologist, neuroradiologist, and neuroscientist -- but you could also call him a “brain photographer.”
 
“I work on multiple sclerosis, and I do that by using MRI machines to take pictures of the brain, and the spinal cord,” said Reich. “That’s opened new doors into understanding how we might treat it, and prevent the disease.”
 
With his research group, Dr. Reich -- whose work is predominantly focused on human imaging research in people with multiple sclerosis (MS) -- has developed and evaluated an imaging approach that detects inflammation of the tissue layer that surrounds the brain, called the meninges. Reich has made several important observations, including showing two major patterns of lesion evolution, which can be used to assess the ultimate degree of tissue damage or recovery. This approach is now being considered for clinical trials of myelin repair therapies in MS.
 
“Dr. Reich’s novel approaches to imaging disease activity in people with multiple sclerosis are creating new pathways to better treatments,” said Dr. Timothy Coetzee, Chief Advocacy, Services and Research Officer at the National MS Society.
 
“Winning the Barancik Prize obviously means a lot to me as a researcher,” said Reich. “I’m really quite thrilled the committee found our work interesting, promising, and innovative.”

About the Barancik Prize for Innovation in MS Research
The Prize seeks to recognize and encourage exceptional innovation and originality in scientific research relevant to multiple sclerosis, with emphasis on impact and potential of the research to lead to pathways for the treatment and cure for MS, and scientific accomplishments that merit recognition as a future leader in MS research. The international prize is made possible by the generosity of the Charles and Margery Barancik SO Foundation, and is administered through the National MS Society.  

Watch a video on Dr. Reich's work and it's impact on people with MS
Read more about the Barancik Prize for Innovation in MS Research

About Multiple Sclerosis

Multiple sclerosis is an unpredictable, often disabling disease of the central nervous system that disrupts the flow of information within the brain, and between the brain and body. Symptoms range from numbness and tingling to blindness and paralysis. The progress, severity and specific symptoms of MS in any one person cannot yet be predicted, but advances in research and treatment are leading to better understanding and moving us closer to a world free of MS. Most people with MS are diagnosed between the ages of 20 and 50, with at least two to three times more women than men being diagnosed with the disease. MS affects more than 2.3 million people worldwide.

Share